So we're not rushing to buy, to say the least. When you combine this with the relatively low insider ownership, we are very cautious about the stock. Looking to the last twelve months, our data doesn't show any insider buying. Insiders sold stock recently, but they haven't been buying. So What Does This Data Suggest About Outset Medical Insiders? We do generally prefer see higher levels of insider ownership. Insiders own 0.6% of Outset Medical shares, worth about US$5.0m, according to our data. A high insider ownership often makes company leadership more mindful of shareholder interests. Does Outset Medical Boast High Insider Ownership?Īnother way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. This may suggest that some insiders think that the shares are not cheap. In total, insiders sold US$94k worth of shares in that time, and we didn't record any purchases whatsoever. The last three months saw significant insider selling at Outset Medical. Outset Medical Insiders Are Selling The Stock While we wait, check out this free list of growing companies with considerable, recent, insider buying. I will like Outset Medical better if I see some big insider buys. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date! NasdaqGS:OM Insider Trading Volume September 10th 2022 You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. Insiders in Outset Medical didn't buy any shares in the last year. So it is hard to draw any strong conclusion from it. The good news is that this large sale was at well above current price of US$18.74. We generally don't like to see insider selling, but the lower the sale price, the more it concerns us. In the last twelve months, the biggest single sale by an insider was when the CEO & Chairman, Leslie Trigg, sold US$144k worth of shares at a price of US$39.77 per share. While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we do think it is perfectly logical to keep tabs on what insiders are doing.īefore we look at these insider transactions though, you might like to know that our analysis indicates that OM is potentially overvalued! The Last 12 Months Of Insider Transactions At Outset Medical Selling at an average price of US$34.18, which is higher than the current price, may have been the best move for these insiders because their investment would have been worth less now than when they sold. Last week, Outset Medical, Inc.'s (NASDAQ:OM) stock jumped 12%, but insiders who sold US$631k worth of stock in over the past year are likely to be in a better position.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |